ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Translational Session

Changing Landscape of Diabetic Kidney Disease Treatment, Including the Robert W. Schrier, MD, Endowed Lectureship

November 02, 2023 | 10:30 AM - 12:30 PM

Location: Ballroom A, Pennsylvania Convention Center

Session Description

The therapeutic landscape of diabetic kidney disease is rapidly evolving. This session opens with a comprehensive overview of the mechanisms of action of novel therapies in the field, as well as unmet needs in the field. Subsequently, updates on recent advances in this arena are provided, with a particular focus on SGLT2 inhibition and GLP1 receptor agonists.

ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier, MD, Endowed Lectureship.

Learning Objective(s)

  • Describe the mechanisms of action of novel therapies in diabetic kidney disease
  • Summarize the unmet needs in the therapeutic landscape of diabetic kidney disease
  • Discuss updates on GLP1 receptor agonists' use
  • Discuss updates on GLP1 receptor agonists' mechanisms and their use

Learning Pathway(s)

  • Diabetic Kidney Disease
  • CKD Non-Dialysis

Moderators

Presentations